REHOVOT, Israel, April 11, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (EVGN), ...
Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 Conference
MORRISTOWN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and ...
EsoGuard ® continues to demonstrate excellent esophageal precancer and cancer detection performance, including in most prevalent and challenging precancer subgroup—short segment non-dysplastic Barrett ...
SAN ANTONIO--(BUSINESS WIRE)--Emtora Biosciences, Inc., a privately-held, San Antonio-based biotechnology company developing a novel reformulated version of a previously-approved drug today announced ...
– Five presentations highlight TERLIVAZ research in adults with HRS with rapid reduction in kidney function, 1 also known as HRS-AKI 2 – Abstract #4243460: Treatment and Outcomes of Terlipressin in ...
BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD Explore TM and AIM-HI UC TM at ...
Latha Alaparthi, MD, gastroenterologist at Gastroenterology Center of Connecticut, talks about lessons she has learned from being a woman in a medical leadership position and what she hopes to teach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results